ホーム > Summary of the Laboratory > Main activites


ここから本文です。

Main Activities

NVAL is responsible for assuring the quality, efficacy and safety of veterinary drugs, veterinary quasi-drugs and medical devices. Our main activities are planning and coordinating of inspections and tests, national assay, distributing of standard products as national reference laboratory. It takes important role to secure animal/human health and food safety. Therefore, we expand our activities like Monitoring on drug-resistant bacteria in the field, Environmental effect assessment of veterinary drugs, Emergency management on exotic virulent diseases by evaluate and stock vaccines for them, etc. An outline of our activity is as follows.
 
<An outline of NVAL's main activities>  
 
 1.Ensuring the quality of veterinary drugs
   (1)To make standards and distributing of standard products
   (2)Internal cooperation on harmonisation of tecnical requirements for registration
       of veterinary drugs(VICH)
   (3)Quality check
      1)National assay on veterinary biological products
      2)Quality testing on antibiotic products by ministerial order
      3)Sampling tests at the distributing stage, and on-site inspections
      4)Tests to evaluate equibalece of biological products
   (4)Tests for quality controll on seed lot system
    (5)Scientific research and study to support guidances and to improve methods of tests
   (6)Technical training and International technical cooperation
 
 2.Technical examination on approval applications
   (1)Inspection to evaluate the confomity to reliability criteria (GLP, GCP, GMP, etc)
   (2)Checking on the information on reevaluatin of veterinary drugs
   (3)Technical examination and consultation on the approval applications
   (4)Data-base on approved drugs, adverse events in the field, etc.
 
 3.For the food safety and Emergency management
   (1)Studies to establish the standards of using veterinary drugs
   (2)Monitoring on drug-resistant bacteria derived from animals in the field
   (3)Emergency management in response to exotic virulent diseases
   (4)Environmental effect assessment of veterinary drugs